{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T22:42:32Z","timestamp":1790462552657,"version":"4.1.0"},"reference-count":216,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1124\/pr.116.012989","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T02:45:18Z","timestamp":1480992318000},"page":"33-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin\/Kexin 9"],"prefix":"10.1016","volume":"69","author":[{"given":"Nabil G.","family":"Seidah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Abifadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annik","family":"Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.116.012989_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11883-014-0439-8","article-title":"Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs","volume":"16","author":"Abifadel","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1124\/pr.116.012989_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.atherosclerosis.2012.04.006","article-title":"Identification and characterization of new gain-of-function mutations in the PCSK9 gene responsible for autosomal dominant hypercholesterolemia","volume":"223","author":"Abifadel","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/humu.20882","article-title":"Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease","volume":"30","author":"Abifadel","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1124\/pr.116.012989_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1124\/pr.116.012989_bib5","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1093\/hmg\/ddv050","article-title":"MBTPS1\/SKI-1\/S1P proprotein convertase is required for ECM signaling and axial elongation during somitogenesis and vertebral development","volume":"24","author":"Achilleos","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.116.012989_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/humu.9383","article-title":"Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia","volume":"26","author":"Allard","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1124\/pr.116.012989_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2013.09.007","article-title":"APOE p.Leu167del mutation in familial hypercholesterolemia","volume":"231","author":"Awan","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.atherosclerosis.2011.08.035","article-title":"The LDLR deficient mouse as a model for aortic calcification and quantification by micro-computed tomography","volume":"219","author":"Awan","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0003319715583205","article-title":"Reducing vascular calcification by anti-IL-1\u03b2 monoclonal antibody in a mouse model of familial hypercholesterolemia","volume":"67","author":"Awan","year":"2016","journal-title":"Angiology"},{"key":"10.1124\/pr.116.012989_bib10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.amjcard.2015.02.006","article-title":"Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin\/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia","volume":"115","author":"Ballantyne","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1124\/pr.116.012989_bib11","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1073\/pnas.96.11.6445","article-title":"Plasmodium falciparum subtilisin-like protease 2, a merozoite candidate for the merozoite surface protein 1-42 maturase","volume":"96","author":"Barale","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib12","doi-asserted-by":"crossref","first-page":"33745","DOI":"10.1074\/jbc.M112.399725","article-title":"Loss- and gain-of-function PCSK9 variants: cleavage specificity, dominant negative effects, and low density lipoprotein receptor (LDLR) degradation","volume":"287","author":"Benjannet","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib13","doi-asserted-by":"crossref","first-page":"48865","DOI":"10.1074\/jbc.M409699200","article-title":"NARC-1\/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol","volume":"279","author":"Benjannet","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib14","doi-asserted-by":"crossref","first-page":"30561","DOI":"10.1074\/jbc.M606495200","article-title":"The proprotein convertase (PC) PCSK9 is inactivated by furin and\/or PC5\/6A: functional consequences of natural mutations and post-translational modifications","volume":"281","author":"Benjannet","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib15","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1073\/pnas.88.9.3564","article-title":"PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues","volume":"88","author":"Benjannet","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib16","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/01.ATV.0000204337.81286.1c","article-title":"Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy","volume":"26","author":"Berge","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.atherosclerosis.2015.01.012","article-title":"PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension","volume":"239","author":"Berger","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.12.017","article-title":"SKI-1\/S1P inhibitor PF-429242 impairs the onset of HCV infection","volume":"115","author":"Blanchet","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1124\/pr.116.012989_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.atherosclerosis.2007.07.019","article-title":"Familial hypercholesterolaemia in Portugal","volume":"196","author":"Bourbon","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000442976","article-title":"Increased plasma PCSK9 levels are associated with reduced endotoxin clearance and the development of acute organ failures during sepsis","volume":"8","author":"Boyd","year":"2016","journal-title":"J Innate Immun"},{"key":"10.1124\/pr.116.012989_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jhep.2014.11.016","article-title":"PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism","volume":"62","author":"Bridge","year":"2015","journal-title":"J Hepatol"},{"key":"10.1124\/pr.116.012989_bib22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1073\/pnas.71.3.788","article-title":"Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity","volume":"71","author":"Brown","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib23","doi-asserted-by":"crossref","first-page":"18609","DOI":"10.1074\/jbc.M115.647180","article-title":"Amyloid precursor-like protein 2 and sortilin do not regulate the PCSK9 convertase-mediated low density lipoprotein receptor degradation but interact with each other","volume":"290","author":"Butkinaree","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib24","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1111\/j.1742-4658.2008.06553.x","article-title":"Investigations on the evolutionary conservation of PCSK9 reveal a functionally important protrusion","volume":"275","author":"Cameron","year":"2008","journal-title":"FEBS J"},{"key":"10.1124\/pr.116.012989_bib25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/hmg\/ddl077","article-title":"Effect of mutations in the PCSK9 gene on the cell surface LDL receptors","volume":"15","author":"Cameron","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.116.012989_bib26","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1021\/bi952552d","article-title":"Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family","volume":"35","author":"Campan","year":"1996","journal-title":"Biochemistry"},{"key":"10.1124\/pr.116.012989_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064145","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) can mediate degradation of the low density lipoprotein receptor-related protein 1 (LRP-1)","volume":"8","author":"Canuel","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.116.012989_bib28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1743-7075-10-4","article-title":"Plasma PCSK9 concentrations during an oral fat load and after short term high-fat, high-fat high-protein and high-fructose diets","volume":"10","author":"Cariou","year":"2013","journal-title":"Nutr Metab"},{"key":"10.1124\/pr.116.012989_bib29","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1161\/ATVBAHA.109.194191","article-title":"PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia","volume":"29","author":"Cariou","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1399-0004.2010.01485.x","article-title":"A presumptive new locus for autosomal dominant hypercholesterolemia mapping to 8q24.22","volume":"79","author":"Cenarro","year":"2011","journal-title":"Clin Genet"},{"key":"10.1124\/pr.116.012989_bib31","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nm.3920","article-title":"PCSK6-mediated corin activation is essential for normal blood pressure","volume":"21","author":"Chen","year":"2015","journal-title":"Nat Med"},{"key":"10.1124\/pr.116.012989_bib32","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2005.01.051","article-title":"A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis","volume":"45","author":"Chen","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/pr.116.012989_bib33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00444","article-title":"SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion","volume":"2","author":"Chen","year":"2013","journal-title":"eLife"},{"key":"10.1124\/pr.116.012989_bib34","doi-asserted-by":"crossref","first-page":"22805","DOI":"10.1074\/jbc.274.32.22805","article-title":"Secreted site-1 protease cleaves peptides corresponding to luminal loop of sterol regulatory element-binding proteins","volume":"274","author":"Cheng","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057857","article-title":"Contribution of common PCSK1 genetic variants to obesity in 8,359 subjects from multi-ethnic American population","volume":"8","author":"Choquet","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.116.012989_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-61779-204-5_2","article-title":"The prohormone theory and the proprotein convertases: it is all about serendipity","volume":"768","author":"Chr\u00e9tien","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.116.012989_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat Genet"},{"key":"10.1124\/pr.116.012989_bib38","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.116.012989_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/db11-0305","article-title":"Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity","volume":"61","author":"Creemers","year":"2012","journal-title":"Diabetes"},{"key":"10.1124\/pr.116.012989_bib40","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.2741\/3055","article-title":"Knock-out mouse models of proprotein convertases: unique functions or redundancy?","volume":"13","author":"Creemers","year":"2008","journal-title":"Front Biosci"},{"key":"10.1124\/pr.116.012989_bib41","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1001\/jama.2009.856","article-title":"Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial","volume":"301","author":"Cruz","year":"2009","journal-title":"JAMA"},{"key":"10.1124\/pr.116.012989_bib42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cca.2014.10.044","article-title":"PCSK9 and its modulation","volume":"440","author":"Cui","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1124\/pr.116.012989_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nsmb1235","article-title":"Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia","volume":"14","author":"Cunningham","year":"2007","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/pr.116.012989_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajhg.2015.11.015","article-title":"Introgression of neandertal- and denisovan-like haplotypes contributes to adaptive variation in human Toll-like receptors","volume":"98","author":"Dannemann","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1124\/pr.116.012989_bib45","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/ATVBAHA.115.306032","article-title":"PCSK9 induces CD36 degradation and affects long-chain fatty acid uptake and triglyceride metabolism in adipocytes and in mouse liver","volume":"35","author":"Demers","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib46","doi-asserted-by":"crossref","first-page":"10805","DOI":"10.1074\/jbc.M113.453373","article-title":"Characterization of proprotein convertase subtilisin\/kexin type 9 (PCSK9) trafficking reveals a novel lysosomal targeting mechanism via amyloid precursor-like protein 2 (APLP2)","volume":"288","author":"DeVay","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib47","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1111\/j.1742-4658.2008.06495.x","article-title":"PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans","volume":"275","author":"Dewpura","year":"2008","journal-title":"FEBS J"},{"key":"10.1124\/pr.116.012989_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001098","article-title":"Evidence for positive selection in the C-terminal domain of the cholesterol metabolism gene PCSK9 based on phylogenetic analysis in 14 primate species","volume":"2","author":"Ding","year":"2007","journal-title":"PLoS One"},{"key":"10.1124\/pr.116.012989_bib49","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1074\/jbc.M114.597229","article-title":"Inhibition of PCSK9 transcription by berberine involves down-regulation of hepatic HNF1\u03b1 protein expression through the ubiquitin-proteasome degradation pathway","volume":"290","author":"Dong","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib50","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1194\/jlr.M003566","article-title":"Strong induction of PCSK9 gene expression through HNF1alpha and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters","volume":"51","author":"Dong","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib51","doi-asserted-by":"crossref","first-page":"258fs41","DOI":"10.1126\/scitranslmed.3010501","article-title":"Bridging lipid metabolism and innate host defense","volume":"6","author":"dos Santos","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1124\/pr.116.012989_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1095\/biolreprod.112.105619","article-title":"Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta","volume":"88","author":"Dub\u00e9","year":"2013","journal-title":"Biol Reprod"},{"key":"10.1124\/pr.116.012989_bib53","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.0000134621.14315.43","article-title":"Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia","volume":"24","author":"Dubuc","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib54","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1194\/jlr.M900273-JLR200","article-title":"A new method for measurement of total plasma PCSK9: clinical applications","volume":"51","author":"Dubuc","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib55","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000682","article-title":"Differential expression of PCSK9 modulates infection, inflammation and coagulation in a murine model of sepsis","author":"Dwivedi","year":"2016","journal-title":"Shock"},{"key":"10.1124\/pr.116.012989_bib56","first-page":"1","article-title":"Proprotein convertase subtilisin\/kexin 9 (PCSK9) inhibitors and the future of dyslipidemia therapy: an updated patent review (2011-2015)","author":"Elbitar","year":"2016","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/pr.116.012989_bib57","doi-asserted-by":"crossref","first-page":"22795","DOI":"10.1074\/jbc.274.32.22795","article-title":"Autocatalytic processing of site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins","volume":"274","author":"Espenshade","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib58","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1074\/jbc.M110.192104","article-title":"In vivo evidence that furin from hepatocytes inactivates PCSK9","volume":"286","author":"Essalmani","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib59","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1073\/pnas.0709428105","article-title":"In vivo functions of the proprotein convertase PC5\/6 during mouse development: Gdf11 is a likely substrate","volume":"105","author":"Essalmani","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib60","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/01.ATV.0000255311.26383.2f","article-title":"A novel loss of function mutation of PCSK9 gene in white subjects with low-plasma low-density lipoprotein cholesterol","volume":"27","author":"Fasano","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib61","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.atherosclerosis.2008.10.027","article-title":"Degradation of LDLR protein mediated by \u2018gain of function\u2019 PCSK9 mutants in normal and ARH cells","volume":"203","author":"Fasano","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bbrc.2008.07.023","article-title":"Inflammation stimulates the expression of PCSK9","volume":"374","author":"Feingold","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.116.012989_bib63","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0140-6736(13)61914-5","article-title":"Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial","volume":"383","author":"Fitzgerald","year":"2014","journal-title":"Lancet"},{"key":"10.1124\/pr.116.012989_bib64","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0006-291X(83)91675-3","article-title":"The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties","volume":"117","author":"Flynn","year":"1983","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.116.012989_bib65","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.115.304660","article-title":"Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia","volume":"115","author":"Fouchier","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/pr.116.012989_bib66","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/CCM.0b013e31827c09f8","article-title":"Benchmarking the incidence and mortality of severe sepsis in the United States","volume":"41","author":"Gaieski","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1124\/pr.116.012989_bib67","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1060458","article-title":"Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein","volume":"292","author":"Garcia","year":"2001","journal-title":"Science"},{"key":"10.1124\/pr.116.012989_bib68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ymeth.2015.03.003","article-title":"A semi-automated mass spectrometric immunoassay coupled to selected reaction monitoring (MSIA-SRM) reveals novel relationships between circulating PCSK9 and metabolic phenotypes in patient cohorts","volume":"81","author":"Gauthier","year":"2015","journal-title":"Methods"},{"key":"10.1124\/pr.116.012989_bib70","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1074\/jbc.M115.686626","article-title":"Deletion of Mbtps1 (Pcsk8, S1p, Ski-1) gene in osteocytes stimulates soleus muscle regeneration and increased size and contractile force with age","volume":"291","author":"Gorski","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib71","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.fob.2014.08.004","article-title":"Is there a link between proprotein convertase PC7 activity and human lipid homeostasis?","volume":"4","author":"Guillemot","year":"2014","journal-title":"FEBS Open Bio"},{"key":"10.1124\/pr.116.012989_bib72","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cmet.2013.12.006","article-title":"The hypercholesterolemia-risk gene SORT1 facilitates PCSK9 secretion","volume":"19","author":"Gustafsen","year":"2014","journal-title":"Cell Metab"},{"key":"10.1124\/pr.116.012989_bib73","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1194\/jlr.M049346","article-title":"Isolation and characterization of the circulating truncated form of PCSK9","volume":"55","author":"Han","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib74","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/jpet.108.139626","article-title":"Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals","volume":"326","author":"Hawkins","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.116.012989_bib75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.apjtm.2016.01.008","article-title":"E670G polymorphism of PCSK9 gene of patients with coronary heart disease among Han population in Hainan and three provinces in the northeast of China","volume":"9","author":"He","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"10.1124\/pr.116.012989_bib76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2009.09.012","article-title":"A chimeric LDL receptor containing the cytoplasmic domain of the transferrin receptor is degraded by PCSK9","volume":"99","author":"Holla","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1124\/pr.116.012989_bib77","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.atherosclerosis.2007.07.022","article-title":"Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa","volume":"196","author":"Homer","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib78","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.atherosclerosis.2006.08.039","article-title":"The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population","volume":"193","author":"Hooper","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib80","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCGENETICS.115.001129","article-title":"Characterization of autosomal dominant hypercholesterolemia caused by PCSK9 gain of function mutations and its specific treatment with alirocumab, a PCSK9 monoclonal antibody","volume":"8","author":"Hopkins","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1124\/pr.116.012989_bib81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/dc14-0473","article-title":"PCSK7 genotype modifies effect of a weight-loss diet on 2-year changes of insulin resistance: the POUNDS LOST trial","volume":"38","author":"Huang","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1124\/pr.116.012989_bib82","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature13408","article-title":"Altitude adaptation in Tibetans caused by introgression of Denisovan-like DNA","volume":"512","author":"Huerta-S\u00e1nchez","year":"2014","journal-title":"Nature"},{"key":"10.1124\/pr.116.012989_bib83","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/01.ATV.20.4.1089","article-title":"Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred","volume":"20","author":"Hunt","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/CIRCGENETICS.109.877811","article-title":"Genetic variation at the proprotein convertase subtilisin\/kexin type 5 gene modulates high-density lipoprotein cholesterol levels","volume":"2","author":"Iatan","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1124\/pr.116.012989_bib85","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1073\/pnas.84.19.6919","article-title":"Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding","volume":"84","author":"Innerarity","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib86","article-title":"PCSK9 inhibition with monoclonal antibodies: modern management of hypercholesterolemia","author":"Ito","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/pr.116.012989_bib87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng0797-303","article-title":"Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene","volume":"16","author":"Jackson","year":"1997","journal-title":"Nat Genet"},{"key":"10.1124\/pr.116.012989_bib88","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/jmedgenet-2014-102670","article-title":"Intake levels of dietary polyunsaturated fatty acids modify the association between the genetic variation in PCSK5 and HDL cholesterol","volume":"51","author":"Jang","year":"2014","journal-title":"J Med Genet"},{"key":"10.1124\/pr.116.012989_bib89","doi-asserted-by":"crossref","first-page":"36551","DOI":"10.1074\/jbc.M502264200","article-title":"Proprotein convertases [corrected] are responsible for proteolysis and inactivation of endothelial lipase","volume":"280","author":"Jin","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib90","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0092-8674(84)90442-2","article-title":"Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-alpha-factor","volume":"37","author":"Julius","year":"1984","journal-title":"Cell"},{"key":"10.1124\/pr.116.012989_bib91","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/eci.12480","article-title":"Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population","volume":"45","author":"Kamani","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1124\/pr.116.012989_bib92","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.75","article-title":"Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans","volume":"40","author":"Kathiresan","year":"2008","journal-title":"Nat Genet"},{"key":"10.1124\/pr.116.012989_bib93","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-9343(64)90196-2","article-title":"The inheritance of essential familial hypercholesterolemia","volume":"37","author":"Khachadurian","year":"1964","journal-title":"Am J Med"},{"key":"10.1124\/pr.116.012989_bib94","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib95","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/MCB.06331-11","article-title":"Loss of endothelial furin leads to cardiac malformation and early postnatal death","volume":"32","author":"Kim","year":"2012","journal-title":"Mol Cell Biol"},{"key":"10.1124\/pr.116.012989_bib96","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1128\/MCB.00764-15","article-title":"Neuroinflammation-induced interactions between protease-activated receptor 1 and proprotein convertases in HIV-associated neurocognitive disorder","volume":"35","author":"Kim","year":"2015","journal-title":"Mol Cell Biol"},{"key":"10.1124\/pr.116.012989_bib97","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000365935","article-title":"Elevated circulating PCSK-9 concentration in renal failure patients is corrected by renal replacement therapy","volume":"40","author":"Konarzewski","year":"2014","journal-title":"Am J Nephrol"},{"key":"10.1124\/pr.116.012989_bib98","first-page":"345","article-title":"Receptor protein tyrosine phosphatase mu expression as a marker for endothelial cell heterogeneity; analysis of RPTPmu gene expression using LacZ knock-in mice","volume":"47","author":"Koop","year":"2003","journal-title":"Int J Dev Biol"},{"key":"10.1124\/pr.116.012989_bib99","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1074\/jbc.M112.421370","article-title":"Low density lipoprotein binds to proprotein convertase subtilisin\/kexin type-9 (PCSK9) in human plasma and inhibits PCSK9-mediated low density lipoprotein receptor degradation","volume":"288","author":"Kosenko","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/500615","article-title":"A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol","volume":"78","author":"Kotowski","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1124\/pr.116.012989_bib101","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1073\/pnas.0712064105","article-title":"Molecular basis for LDL receptor recognition by PCSK9","volume":"105","author":"Kwon","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.22911","article-title":"PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression","volume":"50","author":"Labont\u00e9","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/pr.116.012989_bib103","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/MOL.0000000000000114","article-title":"PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells","volume":"25","author":"Lagace","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/pr.116.012989_bib104","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.116.012989_bib105","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1210\/en.2006-0098","article-title":"Fasting induces hyperlipidemia in mice overexpressing proprotein convertase subtilisin kexin type 9: lack of modulation of very-low-density lipoprotein hepatic output by the low-density lipoprotein receptor","volume":"147","author":"Lambert","year":"2006","journal-title":"Endocrinology"},{"key":"10.1124\/pr.116.012989_bib106","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.bbrc.2009.10.138","article-title":"PCSK9 is expressed in pancreatic delta-cells and does not alter insulin secretion","volume":"390","author":"Langhi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.116.012989_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/09680519030090060701","article-title":"Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice","volume":"9","author":"Lanza-Jacoby","year":"2003","journal-title":"J Endotoxin Res"},{"key":"10.1124\/pr.116.012989_bib108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2016.06.015","article-title":"Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol","volume":"251","author":"Lappeg\u00e5rd","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib109","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1161\/ATVBAHA.112.300263","article-title":"Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1","volume":"33","author":"Le May","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib110","doi-asserted-by":"crossref","first-page":"23385","DOI":"10.1074\/jbc.M115.642991","article-title":"Plasma membrane tetraspanin CD81 complexes with proprotein convertase subtilisin\/kexin type 9 (PCSK9) and low density lipoprotein receptor (LDLR), and its levels are reduced by PCSK9","volume":"290","author":"Le","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib111","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.115.018531","article-title":"Circulating proprotein convertase subtilisin\/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors","volume":"133","author":"Leander","year":"2016","journal-title":"Circulation"},{"key":"10.1124\/pr.116.012989_bib112","doi-asserted-by":"crossref","first-page":"15747","DOI":"10.1074\/jbc.M110.217638","article-title":"Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity","volume":"286","author":"Lei","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib113","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.0009-9163.2004.0238.x","article-title":"Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia","volume":"65","author":"Leren","year":"2004","journal-title":"Clin Genet"},{"key":"10.1124\/pr.116.012989_bib114","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.atherosclerosis.2014.08.038","article-title":"Sorting an LDL receptor with bound PCSK9 to intracellular degradation","volume":"237","author":"Leren","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib115","doi-asserted-by":"crossref","first-page":"28885","DOI":"10.1074\/jbc.M109.052407","article-title":"Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine","volume":"284","author":"Li","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib116","first-page":"382","article-title":"The association between paired basic amino acid cleaving enzyme 4 gene haplotype and diastolic blood pressure","volume":"117","author":"Li","year":"2004","journal-title":"Chin Med J"},{"key":"10.1124\/pr.116.012989_bib117","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1042\/bj3130873","article-title":"Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression","volume":"313","author":"Liao","year":"1996","journal-title":"Biochem J"},{"key":"10.1124\/pr.116.012989_bib118","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/embor.2011.205","article-title":"Mechanistic implications for LDL receptor degradation from the PCSK9\/LDLR structure at neutral pH","volume":"12","author":"Lo Surdo","year":"2011","journal-title":"EMBO Rep"},{"key":"10.1124\/pr.116.012989_bib119","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2014.06.005","article-title":"Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin\/kexin type 9 (PCSK9) gain-of-function mutation","volume":"236","author":"Mabuchi","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib120","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00109-011-0776-9","article-title":"Inactivation of endothelial proprotein convertase 5\/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy","volume":"89","author":"Marchesi","year":"2011","journal-title":"J Mol Med"},{"key":"10.1124\/pr.116.012989_bib121","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/humu.22215","article-title":"Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation","volume":"34","author":"Marduel","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1124\/pr.116.012989_bib122","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ejhg.2010.94","article-title":"A fourth locus for autosomal dominant hypercholesterolemia maps at 16q22.1","volume":"18","author":"Marques-Pinheiro","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1124\/pr.116.012989_bib123","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.1073\/pnas.0402133101","article-title":"Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype","volume":"101","author":"Maxwell","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib124","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1194\/jlr.M300203-JLR200","article-title":"Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mice","volume":"44","author":"Maxwell","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib125","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1373\/clinchem.2011.165191","article-title":"Novel loss-of-function PCSK9 variant is associated with low plasma LDL cholesterol in a French-Canadian family and with impaired processing and secretion in cell culture","volume":"57","author":"Mayne","year":"2011","journal-title":"Clin Chem"},{"key":"10.1124\/pr.116.012989_bib126","doi-asserted-by":"crossref","first-page":"10561","DOI":"10.1074\/jbc.M808802200","article-title":"Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells","volume":"284","author":"McNutt","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib127","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/10320","article-title":"Regulation of anterior\/posterior patterning of the axial skeleton by growth\/differentiation factor 11","volume":"22","author":"McPherron","year":"1999","journal-title":"Nat Genet"},{"key":"10.1124\/pr.116.012989_bib128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/90074","article-title":"Functional analysis of secreted and transmembrane proteins critical to mouse development","volume":"28","author":"Mitchell","year":"2001","journal-title":"Nat Genet"},{"key":"10.1124\/pr.116.012989_bib129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2006.12.035","article-title":"Genetic variants in PCSK9 in the Japanese population: rare genetic variants in PCSK9 might collectively contribute to plasma LDL cholesterol levels in the general population","volume":"196","author":"Miyake","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-291X(88)80832-5","article-title":"Yeast KEX2 genes encode an endopeptidase homologous to subtilisin-like serine proteases","volume":"156","author":"Mizuno","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.116.012989_bib131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jmg.39.4.271","article-title":"Identification of mutations in the gene encoding sterol regulatory element binding protein (SREBP)-2 in hypercholesterolaemic subjects","volume":"39","author":"Muller","year":"2002","journal-title":"J Med Genet"},{"key":"10.1124\/pr.116.012989_bib132","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1161\/01.ATV.0000190668.94752.ab","article-title":"Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response","volume":"25","author":"Naoumova","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib133","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1600-0854.2007.00562.x","article-title":"The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR","volume":"8","author":"Nassoury","year":"2007","journal-title":"Traffic"},{"key":"10.1124\/pr.116.012989_bib134","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.abb.2003.09.011","article-title":"Functional characterization of Narc 1, a novel proteinase related to proteinase K","volume":"420","author":"Naureckiene","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/pr.116.012989_bib135","doi-asserted-by":"crossref","first-page":"12882","DOI":"10.1074\/jbc.M110.113035","article-title":"A proprotein convertase subtilisin-like\/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake","volume":"285","author":"Ni","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib136","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.ATV.0000133684.77013.88","article-title":"Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9","volume":"24","author":"Ouguerram","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib137","doi-asserted-by":"crossref","first-page":"50630","DOI":"10.1074\/jbc.M410077200","article-title":"Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin\/kexin type 9a in mouse liver","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib138","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1194\/jlr.M038331","article-title":"Bile acid and sterol metabolism with combined HMG-CoA reductase and PCSK9 suppression","volume":"54","author":"Parker","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib139","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/17460441.2016.1153626","article-title":"Novel drug discovery approaches for treating arenavirus infections","volume":"11","author":"Pasquato","year":"2016","journal-title":"Expert Opin Drug Discov"},{"key":"10.1124\/pr.116.012989_bib140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.virol.2011.11.008","article-title":"Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1\/site-1 protease inhibitor PF-429242","volume":"423","author":"Pasquato","year":"2012","journal-title":"Virology"},{"key":"10.1124\/pr.116.012989_bib217","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2016.04.011","article-title":"Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution","volume":"250","author":"Patel","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib141","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajhg.2014.01.009","article-title":"Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks","volume":"94","author":"Peloso","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1124\/pr.116.012989_bib142","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2005.08.015","article-title":"Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia","volume":"186","author":"Pisciotta","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157230","article-title":"Trafficking dynamics of PCSK9-induced LDLR degradation: focus on human PCSK9 mutations and C-terminal domain","volume":"11","author":"Poirier","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/pr.116.012989_bib144","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.celrep.2015.11.006","article-title":"GRP94 regulates circulating cholesterol levels through blockade of PCSK9-induced LDLR degradation","volume":"13","author":"Poirier","year":"2015","journal-title":"Cell Reports"},{"key":"10.1124\/pr.116.012989_bib145","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1074\/jbc.M708098200","article-title":"The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2","volume":"283","author":"Poirier","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib146","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12886","article-title":"The complete genome sequence of a Neanderthal from the Altai Mountains","volume":"505","author":"Pr\u00fcfer","year":"2014","journal-title":"Nature"},{"key":"10.1124\/pr.116.012989_bib147","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.116.012989_bib148","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1194\/jlr.P065334","article-title":"PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor\u2019s role","volume":"57","author":"Raal","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib149","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1124\/pr.116.012989_bib150","doi-asserted-by":"crossref","DOI":"10.1093\/molbev\/msw216","article-title":"Signatures of archaic adaptive introgression in present-day human populations","author":"Racimo","year":"2016","journal-title":"Mol Biol Evol"},{"key":"10.1124\/pr.116.012989_bib151","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.pmbts.2015.12.001","article-title":"PCSK1 variants and human obesity","volume":"140","author":"Ramos-Molina","year":"2016","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1124\/pr.116.012989_bib152","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.1073\/pnas.0501652102","article-title":"Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9","volume":"102","author":"Rashid","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1097-2765(00)80006-4","article-title":"Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs","volume":"1","author":"Rawson","year":"1997","journal-title":"Mol Cell"},{"key":"10.1124\/pr.116.012989_bib154","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003323","article-title":"Relationship between low-density lipoprotein cholesterol, free proprotein convertase subtilisin\/kexin type 9, and alirocumab levels after different lipid-lowering strategies","volume":"5","author":"Rey","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1124\/pr.116.012989_bib155","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1017\/S0007114511003436","article-title":"Effect of the Mediterranean diet with and without weight loss on surrogate markers of cholesterol homeostasis in men with the metabolic syndrome","volume":"107","author":"Richard","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1124\/pr.116.012989_bib156","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.116.012989_bib157","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1242\/dev.125.24.4863","article-title":"Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin","volume":"125","author":"Roebroek","year":"1998","journal-title":"Development"},{"key":"10.1124\/pr.116.012989_bib158","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M114.611988","article-title":"Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin\/kexin type 9 through the low density lipoprotein receptor","volume":"290","author":"Romagnuolo","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib159","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1194\/jlr.M061952","article-title":"PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice","volume":"56","author":"Roubtsova","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib160","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/ATVBAHA.110.220988","article-title":"Circulating proprotein convertase subtilisin\/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue","volume":"31","author":"Roubtsova","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib161","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1194\/jlr.M014118","article-title":"PCSK9 reduces the protein levels of the LDL receptor in mouse brain during development and after ischemic stroke","volume":"52","author":"Rousselet","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib162","doi-asserted-by":"crossref","first-page":"43492","DOI":"10.1074\/jbc.M112.394023","article-title":"The M2 module of the Cys-His-rich domain (CHRD) of PCSK9 protein is needed for the extracellular low-density lipoprotein receptor (LDLR) degradation pathway","volume":"287","author":"Saavedra","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib163","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.116.012989_bib164","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fimmu.2013.00387","article-title":"Targeting Toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases","volume":"4","author":"Savva","year":"2013","journal-title":"Front Immunol"},{"key":"10.1124\/pr.116.012989_bib165","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20070150","article-title":"The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in healthy U.K. men","volume":"113","author":"Scartezini","year":"2007","journal-title":"Clin Sci"},{"key":"10.1124\/pr.116.012989_bib166","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cmet.2016.05.023","article-title":"Quantification of GDF11 and myostatin in human aging and cardiovascular disease","volume":"23","author":"Schafer","year":"2016","journal-title":"Cell Metab"},{"key":"10.1124\/pr.116.012989_bib167","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.jmb.2013.11.011","article-title":"An antibody against the C-terminal domain of PCSK9 lowers LDL cholesterol levels in vivo","volume":"426","author":"Schiele","year":"2014","journal-title":"J Mol Biol"},{"key":"10.1124\/pr.116.012989_bib168","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1194\/jlr.M061903","article-title":"Proteolytic cleavage of antigen extends the durability of an anti-PCSK9 monoclonal antibody","volume":"56","author":"Schroeder","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1124\/pr.116.012989_bib169","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.2174\/13816128113199990313","article-title":"Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors in the treatment of hypercholesterolemia and other pathologies","volume":"19","author":"Seidah","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.116.012989_bib170","first-page":"1","article-title":"The PCSK9 revolution and the potential of PCSK9-based therapies to reduce LDL-cholesterol","volume":"59","author":"Seidah","year":"2015","journal-title":"Journal of Global Cardiology Science and Practice"},{"key":"10.1124\/pr.116.012989_bib171","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOL.0000000000000295","article-title":"New developments in proprotein convertase subtilisin-kexin 9's biology and clinical implications","volume":"27","author":"Seidah","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/pr.116.012989_bib172","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCRESAHA.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ Res"},{"key":"10.1124\/pr.116.012989_bib173","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1073\/pnas.0335507100","article-title":"The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation","volume":"100","author":"Seidah","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib174","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0006-8993(99)01909-5","article-title":"Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides","volume":"848","author":"Seidah","year":"1999","journal-title":"Brain Res"},{"key":"10.1124\/pr.116.012989_bib175","series-title":"Molecular Neuroendocrinology: From Genome to Physiology","first-page":"171","article-title":"Posttranslational processing of secretory proteins","author":"Seidah","year":"2016"},{"key":"10.1124\/pr.116.012989_bib176","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1073\/pnas.93.8.3388","article-title":"cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases","volume":"93","author":"Seidah","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib177","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1073\/pnas.81.9.2640","article-title":"Amino acid sequence of homologous rat atrial peptides: natriuretic activity of native and synthetic forms","volume":"81","author":"Seidah","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib178","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.biocel.2008.01.030","article-title":"The activation and physiological functions of the proprotein convertases","volume":"40","author":"Seidah","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/pr.116.012989_bib179","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1073\/pnas.96.4.1321","article-title":"Mammalian subtilisin\/kexin isozyme SKI-1: a widely expressed proprotein convertase with a unique cleavage specificity and cellular localization","volume":"96","author":"Seidah","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib180","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00109-007-0172-7","article-title":"The proprotein convertases are potential targets in the treatment of dyslipidemia","volume":"85","author":"Seidah","year":"2007","journal-title":"J Mol Med"},{"key":"10.1124\/pr.116.012989_bib181","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd3699","article-title":"The biology and therapeutic targeting of the proprotein convertases","volume":"11","author":"Seidah","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.116.012989_bib182","doi-asserted-by":"crossref","first-page":"21473","DOI":"10.1074\/jbc.R113.481549","article-title":"The multifaceted proprotein convertases: their unique, redundant, complementary, and opposite functions","volume":"288","author":"Seidah","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib183","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1073\/pnas.89.18.8822","article-title":"Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3","volume":"89","author":"Smeekens","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib184","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/MOL.0000000000000021","article-title":"Low-density lipoprotein cholesterol reduction by inhibition of PCSK9","volume":"24","author":"Stein","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/pr.116.012989_bib185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MED.0000000000000242","article-title":"What role will proprotein convertase subtilisin\/kexin type 9 inhibitors play in hyperlipidemia management?","volume":"23","author":"Stein","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1124\/pr.116.012989_bib186","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev-med-022613-090402","article-title":"Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9","volume":"65","author":"Stein","year":"2014","journal-title":"Annu Rev Med"},{"key":"10.1124\/pr.116.012989_bib187","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-204-5_1","article-title":"On the discovery of precursor processing","volume":"768","author":"Steiner","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1124\/pr.116.012989_bib188","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1210\/er.2015-1117","article-title":"PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders","volume":"37","author":"Stijnen","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1124\/pr.116.012989_bib189","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCGENETICS.114.000776","article-title":"Exome sequencing in suspected monogenic dyslipidemias","volume":"8","author":"Stitziel","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1124\/pr.116.012989_bib190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2016.02.027","article-title":"Up-regulation of Hnf1\u03b1 gene expression in the liver of rats with experimentally induced chronic renal failure: a possible link between circulating PCSK9 and triacylglycerol concentrations","volume":"248","author":"Sucajtys-Szulc","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.116.012989_bib191","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/hmg\/ddi128","article-title":"Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia","volume":"14","author":"Sun","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.116.012989_bib192","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1101\/gad.479408","article-title":"VACTERL\/caudal regression\/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5","volume":"22","author":"Szumska","year":"2008","journal-title":"Genes Dev"},{"key":"10.1124\/pr.116.012989_bib193","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cell.2015.05.028","article-title":"A single kinase generates the majority of the secreted phosphoproteome","volume":"161","author":"Tagliabracci","year":"2015","journal-title":"Cell"},{"key":"10.1124\/pr.116.012989_bib194","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1124\/pr.116.012989_bib195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCRESAHA.116.308811","article-title":"PCSK9 association with lipoprotein(a)","volume":"119","author":"Tavori","year":"2016","journal-title":"Circ Res"},{"key":"10.1124\/pr.116.012989_bib196","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1096\/fj.02-0831rev","article-title":"Curbing activation: proprotein convertases in homeostasis and pathology","volume":"17","author":"Taylor","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/pr.116.012989_bib197","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/ATVBAHA.116.307493","article-title":"Proprotein convertase subtilisin kexin type 9 inhibition for autosomal recessive hypercholesterolemia-brief report","volume":"36","author":"Thedrez","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1124\/pr.116.012989_bib198","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00439-003-1071-9","article-title":"A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree","volume":"114","author":"Timms","year":"2004","journal-title":"Hum Genet"},{"key":"10.1124\/pr.116.012989_bib199","article-title":"Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor","volume":"11","author":"Topchiy","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/pr.116.012989_bib200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/1389202911314050010","article-title":"Genetics of the first seven proprotein convertase enzymes in health and disease","volume":"14","author":"Turpeinen","year":"2013","journal-title":"Curr Genomics"},{"key":"10.1124\/pr.116.012989_bib201","doi-asserted-by":"crossref","DOI":"10.3390\/v8020046","article-title":"Suppressive effects of the site 1 protease (S1P) inhibitor, PF-429242, on dengue virus propagation","volume":"8","author":"Uchida","year":"2016","journal-title":"Viruses"},{"key":"10.1124\/pr.116.012989_bib202","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/br.2015.484","article-title":"Association of FURIN and ZPR1 polymorphisms with metabolic syndrome","volume":"3","author":"Ueyama","year":"2015","journal-title":"Biomed Rep"},{"key":"10.1124\/pr.116.012989_bib203","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/302370","article-title":"A third major locus for autosomal dominant hypercholesterolemia maps to 1p34.1-p32","volume":"64","author":"Varret","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1124\/pr.116.012989_bib204","doi-asserted-by":"crossref","first-page":"258ra143","DOI":"10.1126\/scitranslmed.3008782","article-title":"PCSK9 is a critical regulator of the innate immune response and septic shock outcome","volume":"6","author":"Walley","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1124\/pr.116.012989_bib205","doi-asserted-by":"crossref","first-page":"16659","DOI":"10.1074\/jbc.M116.717736","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation","volume":"291","author":"Weider","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib206","doi-asserted-by":"crossref","first-page":"17362","DOI":"10.1073\/pnas.1314698110","article-title":"Disruption of the expression of the proprotein convertase PC7 reduces BDNF production and affects learning and memory in mice","volume":"110","author":"Wetsel","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib207","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1734-1140(12)70883-6","article-title":"Berberine inhibits dyslipidemia in C57BL\/6 mice with lipopolysaccharide induced inflammation","volume":"64","author":"Xiao","year":"2012","journal-title":"Pharmacol Rep"},{"key":"10.1124\/pr.116.012989_bib208","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1074\/jbc.M110.199042","article-title":"A two-step binding model of PCSK9 interaction with the low density lipoprotein receptor","volume":"286","author":"Yamamoto","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib209","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1073\/pnas.150149097","article-title":"Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme","volume":"97","author":"Yan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib210","doi-asserted-by":"crossref","first-page":"13607","DOI":"10.1073\/pnas.201524598","article-title":"Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene","volume":"98","author":"Yang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib211","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/CIRCULATIONAHA.114.010696","article-title":"Integromic analysis of genetic variation and gene expression identifies networks for cardiovascular disease phenotypes","volume":"131","author":"Yao","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/pr.116.012989_bib212","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/humu.20316","article-title":"The c.43_44insCTG variation in PCSK9 is associated with low plasma LDL-cholesterol in a Caucasian population","volume":"27","author":"Yue","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1124\/pr.116.012989_bib213","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.22354","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration","volume":"48","author":"Zaid","year":"2008","journal-title":"Hepatology"},{"key":"10.1124\/pr.116.012989_bib214","doi-asserted-by":"crossref","first-page":"13045","DOI":"10.1073\/pnas.0806312105","article-title":"Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.116.012989_bib215","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation","volume":"282","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.116.012989_bib216","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am J Hum Genet"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724012122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724012122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.116.012989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T10:54:45Z","timestamp":1739876085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724012122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":216,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0031699724012122"],"URL":"https:\/\/doi.org\/10.1124\/pr.116.012989","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Proprotein Convertases in Hypercholesterolemia and Cardiovascular Diseases: Emphasis on Proprotein Convertase Subtilisin\/Kexin 9","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.116.012989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}